1. Home
  2. METC vs XERS Comparison

METC vs XERS Comparison

Compare METC & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ramaco Resources Inc.

METC

Ramaco Resources Inc.

HOLD

Current Price

$15.59

Market Cap

1.0B

Sector

Energy

ML Signal

HOLD

XERS

Xeris Biopharma Holdings Inc.

HOLD

Current Price

$6.15

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
METC
XERS
Founded
2015
2005
Country
United States
United States
Employees
900
N/A
Industry
Coal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
METC
XERS
Price
$15.59
$6.15
Analyst Decision
Strong Buy
Buy
Analyst Count
8
6
Target Price
$34.00
$10.83
AVG Volume (30 Days)
1.4M
1.6M
Earning Date
05-08-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
100.00
EPS
N/A
0.01
Revenue
N/A
$49,590,000.00
Revenue This Year
$19.61
$34.37
Revenue Next Year
$11.96
$22.86
P/E Ratio
N/A
$633.00
Revenue Growth
N/A
142.67
52 Week Low
$8.51
$4.30
52 Week High
$57.80
$10.08

Technical Indicators

Market Signals
Indicator
METC
XERS
Relative Strength Index (RSI) 54.95 48.72
Support Level $15.08 $5.81
Resistance Level $16.20 $6.41
Average True Range (ATR) 1.22 0.27
MACD 0.16 -0.01
Stochastic Oscillator 65.95 40.48

Price Performance

Historical Comparison
METC
XERS

About METC Ramaco Resources Inc.

Ramaco Resources Inc is a United States-based company that operates as a pure-play metallurgical coal company with operations in southern West Virginia and southwestern Virginia. Its portfolio includes high-quality metallurgical coal reserves & resources, with a focus on properties such as Elk Creek, Berwind, Knox Creek, and Maben. These properties are strategically located to serve North American blast furnace steel mills and coke plants, as well as international metallurgical coal consumers. Additionally, the company controls mineral deposits in Sheridan, Wyoming, exploring potential opportunities in rare earth elements and coal-to-carbon-based products. The company's two operating segments are Metallurgical Coal segment; and Rare Earths and Critical Minerals.

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.

Share on Social Networks: